This site is intended for healthcare professionals only
LoginRegister
Patanjali challenges Delhi HC for disparaging chyawanprash adsHC Allows B.Pharm Graduates to Apply for Pharmacist Posts, Calls Diploma-Only Clause Arbitrary
Aster DM Healthcare appoints Sudeep Dey as CIO, CISOAster DM Healthcare, India appoints Sudeep Dey as CIO, CISO
Roche gets CE mark for Elecsys Dengue Ag test to diagnose dengueNo Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India
Zydus Wellness net sales up by 31 percent in Q2 FY26Zydus Wellness incorporates wholly owned subsidiary in UK
Alembic Pharma gets USFDA nod for angina drug Diltiazem HydrochlorideTeva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention
CDSCO Panel Recommends Updating Prescribing Information for Sanofis VaccineSanofi completes acquisition of Vigil Neuroscience
SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab BiosimilarNPPA Caps Prices of Ipratropium, Sodium Nitroprusside, Two Other Essential Drugs
Asks Akums for Detailed Data on Phase III Eye Drop TrialAkum Pharma Asked to Submit Safety Data for Alzheimer's Drug Combo In Elderly Indian Patients
net profit dropsAurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB PatientsMSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety Caveat
USFDA appoints Sean Keveney as Chief CounselUSFDA appoints Sean Keveney as Chief Counsel
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsBristol Myers Squibb Breyanzi application accepted for priority review by USFDA for Marginal Zone...
X